Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • maoyanjun
    Junior Member
    • Dec 2013
    • 4

    #1

    Cancer panel v2,low quality,316v2

    Hi, these days ,I run some 316v2 chips on PGM, and the %low quality show very high, ranged from 27-40%! Can anyone tell me why?
  • JPC
    Senior Member
    • May 2008
    • 116

    #2
    We run a Proton and found that we improved our quality by reducing the quantity of DNA that goes into the emPCR by by 20%, we now do this is standard

    JPC

    Comment

    • maoyanjun
      Junior Member
      • Dec 2013
      • 4

      #3
      Originally posted by JPC View Post
      We run a Proton and found that we improved our quality by reducing the quantity of DNA that goes into the emPCR by by 20%, we now do this is standard

      JPC
      Thank you for your reply!
      We had try that before, but it didn't work!
      by the way, how do you quantify the library, 2100 or qubit?

      Comment

      • JPC
        Senior Member
        • May 2008
        • 116

        #4
        qubit for quant, but we also use the bioanalyser tp make sure the profile looks as expected (no primer etc.)

        JPC

        Comment

        • maoyanjun
          Junior Member
          • Dec 2013
          • 4

          #5
          Originally posted by JPC View Post
          qubit for quant, but we also use the bioanalyser tp make sure the profile looks as expected (no primer etc.)

          JPC
          thank you very much

          Comment

          • mikeg
            Member
            • Aug 2013
            • 13

            #6
            You probably need to check amplifiability of your DNA. Using the RNaseP kit will help out with that. Crap in, crap out.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            14 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            21 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-13-2026, 09:56 AM
            0 responses
            19 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-09-2026, 11:14 AM
            0 responses
            27 views
            0 reactions
            Last Post SEQadmin2  
            Working...